Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Try Rising P/E Investing With 5 Top-Ranked Stocks

Published 10/31/2019, 06:52 AM
Updated 07/09/2023, 06:31 AM

One of the most common forms of investing techniques is running after stocks with a low price-to-earnings (P/E) ratio. That’s because this basic measure of how much investors are spending for $1 worth of earnings speaks of undervaluation. The logic is simple — a stock’s current market price does not justify its higher earnings and therefore leaves room for upside.

But have you ever given it a thought that stocks with a rising P/E can also be worth buying. We’ll tell you why.

How Does Increasing P/E Theory Work?

The concept is that as earnings rise, the price of a stock goes up. As forecasts for expected earnings come in higher, strong demand for the stock should continue to push up its prices.

A stock's P/E gives an indication of how much investors are ready to shell out per dollar of earnings. So, if the P/E of a stock is rising steadily, it means that investors are assured of its inherent strength and believe that more positives are to come out of it.

Also, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.

The Winning Strategy

In order to shortlist stocks that are exhibiting an increasing P/E, we chose the following as our primary screening parameters.

EPS growth estimate for the current year is greater than or equal to last year’s actual growth

Percentage change in last year EPS should be greater than or equal to zero

(These two criteria point to flat earnings or a growth trend over the years.)

Percentage change in price over four weeks greater than the percentage change in price over 12 weeks

Percentage change in price over 12 weeks greater than percentage change in price over 24 weeks

(These two criteria show that price of the stock is increasing consistently over the said time frames.)

Percentage price change for four weeks relative to the S&P 500 greater than the percentage price change for 12 weeks relative to the S&P 500

Percentage price change for 12 weeks relative to the S&P 500 greater than the percentage price change for 24 weeks relative to the S&P 500

(Here, the case for consistent price gains gets even stronger as it displays percentage price changes relative to the S&P 500.)

Percentage price change for 12 weeks is 20% higher than or equal to the percentage price change for 24 weeks, but it should not exceed 100%

(A 20% increase in the price of a stock from the breakout point gives cues of an impending uptrend. But a jump of over 100% indicates that there is limited scope for further upside and that the stock might be due for a reversal.)

In addition, we place a few other criteria that lead us to some likely outperformers.

Zacks Rank less than or equal to 2: Only companies with a Zacks Rank #1 (Strong Buy) or 2 (Buy) can get through.

Average 20-day Volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.

Just these few factors narrowed down the universe from over 7,700 stocks to just 42.

Here are five of 42 stocks that passed the screen:

Avinger Inc. (NASDAQ:AVGR) : This company is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. It belongs to a top-ranked Zacks industry (top 23%) and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

TripAdvisor Inc. (NASDAQ:TRIP) : This #2 Ranked company is one of the largest online travel research companies in the world. It comes from a top-ranked Zacks industry (top 17%).

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) : This is a biopharmaceutical company focused on the development and commercialization of life-transforming drugs for the treatment of patients with ultra-rare disorders. The company belongs to a top-ranked Zacks industry (top 27%) and carries a Zacks Rank #2.

Check Point Software Technologies Ltd. (NASDAQ:CHKP) : This provider of information technology security solutions across the world comes from a top-ranked Zacks industry (top 33%). It carries a Zacks Rank #2.

ServiceNow Inc. (NYSE:NOW) : This company provides cloud computing services that automate digital workflows to accelerate enterprise IT operations. The Zacks Rank #2 stock hails from a top-ranked Zacks industry (top 32%).

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.



TripAdvisor, Inc. (TRIP): Free Stock Analysis Report

ServiceNow, Inc. (NOW): Free Stock Analysis Report

Check Point Software Technologies Ltd. (CHKP): Free Stock Analysis Report

Avinger, Inc. (AVGR): Free Stock Analysis Report

Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.